Current methods and factors to take into account for viral clearance in cell and gene therapy
59:51
Current practices and considerations of cell and gene therapy method validation controls
1:02:21
Lunch & Learn: Intro to Viral Vectors
1:03:24
Lunch & Learn: Gene Therapy 101
55:01
BioPhorum Drug Substance workstreams: Cell Banks, LIVCA & Multi Product Facility
44:30
Part 2/3 - Navigating the cell and gene therapy supply chain insights, practices and distinctions
27:24
Assuring Viral Safety of the Biopharmaceutical Process
38:32
Environmental monitoring performance qualification
1:09:59